LOW-risk evidence brief
A practical checklist for comparing online GLP-1 provider fees
By Clinic Scout Editorial Team · no clinical credentials claimed · updated 2026-07-23

Direct answer
Compare provider fees by requesting an itemized written quote that separates intake, membership, clinician care, medication, labs, supplies, shipping, and cancellation or renewal obligations. Record the amount due today and full minimum-term total. Treat ‘from’ prices, annual-plan rates, insurance support, HSA/FSA language, and unstated fields as qualifiers—not proof of an all-in price.
| Provider | Starting price | Medications offered | Insurance | Average wait | Clinic Scout score | Public review signal | Next steps |
|---|---|---|---|---|---|---|---|
| Found | Compounded options advertised from $99/month; membership and medication costs may be separate | Branded and compounded prescription options; availability and eligibility vary | Free insurance check and carrier support are described; coverage remains plan-specific | Many members may start within a week; not guaranteed | 6.6/10 | ||
| yourEra | Compounded semaglutide from $99/month; compounded tirzepatide from $169/month | Compounded semaglutide and compounded tirzepatide | Self-pay; no insurance required; HSA/FSA treatment depends on the administrator | Not stated | 6.5/10 | ||
| Trimi | Compounded semaglutide from $99/month and compounded tirzepatide from $125/month on annual plans | Compounded semaglutide and compounded tirzepatide | Self-pay; states HSA/FSA eligibility | Not stated | 6.4/10 | ||
| Shed | GLP-1 injection program advertised from $199/month; medication and dose may change price | Branded and compounded GLP-1 options; prescription and availability vary | Insurance or cash-pay options are described; support is not a coverage guarantee | Not stated | 6.1/10 | ||
| Gala GLP-1 | Compounded GLP-1/GIP advertised from $179/month on a yearly subscription plan | Compounded GLP-1/GIP and selected branded options | Self-pay; insurance not required | Not stated | 5.5/10 | ||
| Oak Longevity | Program advertised from $119/month; page metadata exposes other figures, so checkout verification is required | Semaglutide and tirzepatide options are described | Insurance process is not stated clearly enough to treat as coverage support | Not stated | 5.3/10 |
Request the same fee categories from every provider
Start with a blank fee matrix rather than the provider's marketing layout. Use rows for intake, membership, clinician review, follow-up visits or messaging, medication, labs, supplies, shipping, taxes or other charges if applicable, cancellation, and renewal. Ask each provider to mark every row as included, separately billed, variable, or not applicable. This creates comparable categories even when one company emphasizes a medication price and another emphasizes a program subscription.
Require a written source for each amount. The ideal evidence is the current official product page plus the prepayment checkout summary, terms, and a dated support response for anything ambiguous. A search result, coupon site, testimonial, or old article can suggest a question but should not set the number in the matrix. The Phase 2 provider ledger was checked on 2026-07-23 and therefore serves as a dated starting point, not a promise that any price remains available.
Do not write zero for an unstated fee. For example, Gala's reviewed evidence described a nationwide pharmacy network but did not state the shipping fee; the matrix should say ‘not stated.’ Found's ledger says medication and membership or clinical-care pricing may be separate; the matrix should request both. Oak's page metadata exposed differing price points; the matrix should use the current checkout quote, not whichever number is lower. Unknowns are decision-relevant evidence.
Separate the displayed rate from the obligation
Every quote needs four timing fields: amount due today, recurring amount, billing cadence, and full minimum-term obligation. Trimi's lowest advertised prices were tied to an annual plan, and Gala's $179 starting figure was tied to a yearly subscription. A per-month normalization can be accurate while still hiding the contract's financial exposure. Ask whether the amount is prepaid or billed in installments, when it renews, and what charges remain after cancellation.
Compare the first month and full minimum term separately. This prevents a month-to-month or uncertain-duration offer from being ranked against an annual-plan rate without a qualifier. It also exposes onboarding or initial fees that a later recurring price may omit. If the provider will not state a minimum obligation before payment, mark commitment clarity as a con. Do not assume favorable cancellation, pause, refund, or renewal terms that are absent from the ledger.
Price-change conditions deserve their own field. Shed's ledger says medication and dose can change price. Found says medication and membership or clinical-care costs vary. Product availability and eligibility can also affect quotes. Record which event can change the amount, when notice is provided, and whether the consumer can decline. A range or variable field is not a flaw by itself, but it must not be presented as a fixed all-in total.
Compare service scope, not just medication price
Provider pages describe different service bundles. Found mentions clinician assessment review and monthly check-ins. yourEra describes licensed-provider intake review and ongoing care-team messaging. Trimi describes licensed-provider review through Arora Health. Shed describes provider-led care, follow-ups, and health coaching. Gala describes state-licensed provider review. Oak describes doctor review of submitted information. These statements show that a service process exists; they do not prove identical access, cadence, or value.
Turn each broad service statement into fee questions. How many scheduled contacts are included? Is messaging included or charged separately? Is coaching part of the starting amount? Are labs required, and if so who bills them? Are supplies included? What happens if additional review is requested? Keep the questions operational. This no-clinician guide cannot assess whether a care model is medically better, and it does not claim that more contacts produce better outcomes.
Average wait time was not stated for yourEra, Trimi, Shed, or Gala in the ledger, and Found's statement that many members can start within a week is not guaranteed. Do not infer service speed from shipping method. Trimi's free overnight shipping can be recorded as shipping specificity, not an intake-to-start promise. Ask for the current timeline by stage and avoid paying an expedited premium unless its scope and refund terms are clear.
Handle shipping, location, and payment support carefully
Shipping is one of the easier fees to verify, but the sources still differ. yourEra and Shed state free shipping, Trimi states free overnight shipping, Oak states free tracked delivery, Found says medication ships when prescribed without a fee fact in the ledger, and Gala does not state a shipping fee in the reviewed evidence. Record only the sourced statement. Also ask whether supplies, replacement shipments, damaged packages, and address changes can generate costs.
Service area can change whether a quote is usable. yourEra and Trimi state all-50-state availability; Gala states licensed providers in all 50 states; Found is available only in listed states; Shed's service area was not fully enumerated; and Oak's was not stated. A national statement does not guarantee every product in every state or individual eligibility. Confirm the exact service and product for the consumer's location before treating the quote as actionable.
Payment-support language must remain distinct from price. Found's free insurance check and Shed's insurance-or-cash-pay options may help a consumer explore benefits, but they do not guarantee coverage. yourEra's HSA/FSA use may depend on an administrator, and Trimi's HSA/FSA statement likewise should be verified. Put insurer responsibility, self-pay charges, and possible account use in separate fields. Combining them can make the provider fee look lower than the consumer's real economic cost.
Keep regulatory product categories visible
The provider fee matrix must identify whether the quote involves a branded FDA-approved product or a compounded product. Found and Shed describe both branded and compounded pathways, while yourEra and Trimi list compounded semaglutide and compounded tirzepatide, and Gala describes compounded plus selected branded options. Oak describes semaglutide and tirzepatide options, but its ledger excludes a same-active-ingredient equivalence claim. Do not collapse these descriptions into one interchangeable product row.
FDA states that compounded drugs are not FDA-approved and do not receive FDA premarket review for safety, effectiveness, and quality. That fact belongs beside compounded quotes so a low fee is not mistaken for regulatory equivalence. The fee comparison must not claim that a compounded product is a generic equivalent, safer, less safe, more effective, or less effective based on price. Those are not supported commercial conclusions, and treatment decisions require a qualified healthcare professional.
Product labels also protect the accuracy of a cheapest-option claim. A branded insured quote, a compounded self-pay annual rate, and a variable-dose program may all have different totals, but ranking them as equivalent purchases would mislead. Either compare within the same clearly defined category or present parallel scenarios without one overall winner. If the exact product is unknown until review, label the quote provisional and delay the ranking.
Score transparency and retain real cons
A fee comparison can score transparency without pretending to score medical quality. Award commercial clarity for a published product-specific amount, explicit commitment, clear included services, stated shipping fee, documented payment pathway, and current cancellation terms. Deduct or flag uncertainty for variable pricing without a range, conflicting metadata, separate unstated fees, missing service area, or an unclear minimum obligation. Do not award points for testimonials, outcome percentages, or promotional superlatives.
The provider examples yield genuine cons. Found may separate medication and care costs. yourEra leaves average wait unstated and HSA/FSA use administrator-dependent. Trimi's lowest rates require an annual plan. Shed's price can vary with medication or dose and its service area needs verification. Oak exposes differing starting-price figures and does not state service area. Gala's yearly-plan figure comes with an unstated shipping fee. A commercial relationship does not remove any of those limitations.
Close the process by saving the itemized quote, checkout summary, terms, cancellation method, and dated provider answers. Recalculate before renewal. Commission must not determine inclusion or scoring, and any affiliate CTA needs a clear inline disclosure before the link. Finally, keep the boundary: this checklist compares fees and terms only. It cannot determine eligibility, product choice, risks, or treatment. When the rows are not comparable or material fields remain unknown, decline to name a cheapest provider.
Add a reconciliation step after the first invoice. Compare every line against the saved quote and note whether the charge was expected, variable within a disclosed rule, or unexplained. Contact the provider promptly about unexplained differences and retain the written response. This turns fee comparison into an ongoing control rather than a one-time shopping exercise. It also reveals whether an apparently clear offer remains clear after fulfillment without using a testimonial or generalizing one consumer's experience into a provider-wide claim.
Finally, establish an update trigger. Reopen the comparison when the product, dose, insurance path, membership tier, state, shipping terms, or renewal date changes. Use the newest official source and archive the prior version rather than overwriting the evidence trail. A fee verdict should expire when its inputs change. That rule may prevent a permanent ranking, but it produces a more honest commercial guide and reduces the chance that a dated ‘from’ price becomes an unsupported current promise. Assign every comparison a next-review date even when no change is reported. On that date, confirm each source URL still resolves, capture the current price qualifier, and check whether a previously unstated fee now appears. If the evidence cannot be refreshed, remove the specific fee verdict rather than carrying it forward on trust.
Sources
- Found · supports provider-fee-facts · checked 2026-07-23
- yourEra · supports provider-fee-facts · checked 2026-07-23
- Trimi · supports provider-fee-facts · checked 2026-07-23
- Shed · supports provider-fee-facts · checked 2026-07-23
- Oak Longevity · supports provider-fee-facts · checked 2026-07-23
- Gala GLP-1 · supports provider-fee-facts · checked 2026-07-23
- U.S. Food and Drug Administration · supports compounded-status · checked 2026-07-23
- U.S. Food and Drug Administration · supports compounded-status · checked 2026-07-23
- Federal Trade Commission · supports affiliate-disclosure · checked 2026-07-23
Next step
Use one itemized matrix, compare amount due today and full minimum-term obligation, preserve unknowns, and name no cheapest provider unless products, service scope, and payment pathways are truly comparable.
Compare your priorities privately